- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02472197
Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (RESMO)
Intrauterine pathologies are currently treated by hysteroscopic resection. In this surgical procedure, the intrauterine pathology is resected by a transcervical approach in several fragments using a mono or bipolar cove after distension of the uterine cavity and by endoscopic control. The main risks of this surgery are: uterine perforation and OHIA (operative hysteroscopy intravascular absorption) syndrome. Hysteroscopic morcellators are new intrauterine devices, recently appeared on the French market.
In comparison to classical resectors, morcellators have several theoretical advantages:
- A smaller instrument diameter with potentially a lower risk of uterine perforation and cervical laceration during the dilatation procedure,
- The use of physiological serum, eliminating the risk of neurological toxicity of glycine,
- The risk of electrical accident is canceled (internal or external burns due to leakage current),
- A decreased risk of air embolism, due to the absence of bubbles' production,
- The instrument is always under visual control, the perforation risk by the active instrument is therefore very limited,
- The vision is not obscured by the fragments or by the bubbles,
- The treatment of pre-ostial pathologies, not always easy in classical resections, could be facilitated,
- the absence of thermal effect, and therefore a potentially lower endometrial aggression, is interesting in women with reproductive desire,
- Absence of chips management, limiting the entry and exit movements in the uterine cavity, improving the vision, reducing the infectious and traumatic risks, specially uterine perforation and air embolism,
- Morcellation could preserve tissues for histological analysis of possible malignancy (compared to techniques using heat, coagulation, vaporization),
- Easy learning in comparison to the time-consuming learning of classical hysteroscopic resection,
- Generated additional cost could be partly amortized by reducing operating time and complications.
It seemed useful to study this new technology.
The primary purpose was to compare the time of hysteroscopic treatment of uterine polyps between a hysteroscopic morcellator the UNIDRIVE S III / DrillCut-X II-GYN-Shaver (Integrated Bigatti Shaver IBS), Storz®, and a conventional resectoscope.
The secondary purposes were to compare the efficiency, complications and comfort of these techniques.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67000
- University Hospital, Strasbourg, France
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All major patients with single endometrial polyp,
- Confirmed by a diagnostic hysteroscopy
- Greater than or equal to one centimeter in size with no upper size limit
- Patient giving informed consent
- Subject belonging to a social security organisme
Exclusion Criteria:
- Ongoing pregnancy or breastfeeding
- Progressive malignant gynecological pathology
- Evolutionary Genital infection
- Suspected malignancy before surgery
- Multiple Polyps
- Polypoid hyperplasia
- Associated submucosal myoma
- Person under guardianship
- Patient with contraindication to general anesthesia or spinal anesthesia
- Person in an exclusion period (determined by a previous or ongoing study)
- Inability to give the eprosn informed information (comprehension difficulties ...)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: morcellation
|
The endometrial polyp is resected by a transcervical approach.
During the procedure, the polyp is placed by suction against the window of the device, then cut by mechanical energy, in chips which are directly aspirated by the device.
|
Active Comparator: standard resection
|
The endometrial polyp is resected by a transcervical approach in several chips using a mono or bipolar cove after distension of the uterine cavity under endoscopic control.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Morcellation or resection time (minutes)
Time Frame: From the cervical dilatation just before introducing the operative device until removal of the operative device assessed up to 25 minutes
|
From the cervical dilatation just before introducing the operative device until removal of the operative device assessed up to 25 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The completeness of resection or not,
Time Frame: 10 weeks after surgery
|
10 weeks after surgery
|
|
The total operating time (in minutes):
Time Frame: from the beginning of diagnostic hysteroscopy to the end of operative hysteroscopy resection and removal of the operative device, assessed up to 25 minutes
|
from the beginning of diagnostic hysteroscopy to the end of operative hysteroscopy resection and removal of the operative device, assessed up to 25 minutes
|
|
The amount of serum used (mL)
Time Frame: At the end of surgery
|
At the end of surgery
|
|
Perioperative complications,
Time Frame: 10 weeks after surgery
|
10 weeks after surgery
|
|
The quality of vision defined by the operator on a scale of 0 to 5,
Time Frame: At the end of surgery
|
At the end of surgery
|
|
Persistence or not of the disease
Time Frame: 10 weeks after surgery
|
evaluated by hysteroscopy
|
10 weeks after surgery
|
The occurrence of secondary adhesions
Time Frame: 10 weeks after surgery
|
10 weeks after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Olivier GARBIN, MD, University Hospital, Strasbourg, France
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6043
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrial Polyps
-
IRCCS Burlo GarofoloCompletedAtypical Endometrial Hyperplasia | Atypical Endometrial PolypsItaly
-
Birmingham Women's NHS Foundation TrustSmith & Nephew, Inc.CompletedEndometrial PolypsUnited Kingdom
-
Ullevaal University HospitalCompletedEndometrial Cancer | Endometrial PolypNorway
-
University of CagliariUnknown
-
Henry Aristoteles Mate-SánezCompletedEndometrial Polyps in Infertile Patients
-
University Magna GraeciaUnknown
-
Peking Union Medical College HospitalCompleted
-
Arie Lissak, MDUnknownEndometrial Polyp. | Malignant and Pre-malignant Changes in the PolypIsrael
-
Muğla Sıtkı Koçman UniversityCompleted
-
Isabel Bejerano BlázquezHospital Universitario Reina Sofia de Cordoba; Universidad Nacional de CórdobaCompleted
Clinical Trials on Hysteroscopic morcellation
-
Universitaire Ziekenhuizen KU LeuvenZiekenhuis Oost-LimburgCompletedMyoma;Uterus | Retained Products of Conception | Endometrial Polyp BenignBelgium
-
George Washington UniversityWithdrawn
-
University Magna GraeciaCompleted
-
Ege UniversityCompleted
-
Università degli Studi dell'InsubriaNot yet recruiting
-
Far Eastern Memorial HospitalRecruitingHysteroscopic MyomectomyTaiwan
-
Brugmann University HospitalWithdrawnSymptomatic Submucosal MyomaBelgium, France
-
Shanghai First Maternity and Infant HospitalUnknownCesarean Section ScarChina
-
Università degli Studi dell'InsubriaUniversity of Ljubljana; Università degli Studi di BresciaCompleted
-
University Hospital, GhentCompletedLarge Intrauterine Polyps | Smaller Type 0 and 1 Myomas | Residual Placental TissueBelgium, Netherlands